CAN
NYMX

Cetera Advisor Networks’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Cetera Advisor Networks’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-118,900
Closed -$22.6K – 2830
2023
Q2 		$22.6K Hold
118,900
– – ﹤0.01% 2550
2023
Q1 		$40.4K Buy
118,900
+51,775
+77% +$21K ﹤0.01% 2505
2022
Q4 		$21.7K Buy
67,125
+50,000
+292% +$18.1K ﹤0.01% 2481
2022
Q3 		$7K Buy
+17,125
New +$6.81K ﹤0.01% 2068

Other funds holding NYMX

DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
FCFC
First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
ODIJL
One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

Cetera Advisor Networks's NYMX Position: Q3 2023 in Review

Cetera Advisor Networks sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 118,900 shares — an estimated $22.6K sold.

Cetera Advisor Networks first reported a position in NYMX in Q3 2022 and held it in 4 quarters. The position peaked at $40.4K in Q1 2023. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

  • Cetera Advisor Networks reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
  • Cetera Advisor Networks sold 118,900 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $22.6K.
  • Cetera Advisor Networks first reported a position in Nymox Pharmaceutical Corp in Q3 2022 and held it in 4 quarters.
  • Cetera Advisor Networks's Nymox Pharmaceutical Corp position peaked at $40.4K in Q1 2023.
  • 5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on Cetera Advisor Networks's 13F filing for Q3 2023, filed 14 Nov 2023.